fixed income

Combined AUM of $8bn now in ABS

Follows fund registration in UK

Seeking sterling share classes

Investors return to funds ahead of ISA deadline

The pharmaceutical and biotechnology sector has performed well in recent years, primarily by virtue of attractive fundamentals.

Inflows resume in March

Aim to deliver in excess of LIBOR

Cuts in Europe and US

Joins from Royal Bank of Scotland

Replacements to be announced